In this episode of Vital Psychedelic Conversations, David Drapkin interviews Andrew Tatarsky, Ph.D.; author and developer of Integrative Harm Reduction Psychotherapy, and Juliana Mulligan; writer and head of Inner Vision Ibogaine. Both are part of The Center for Optimal Living in NYC (CFOL); Tatarsky as the Founder and Director, and Mulligan as the Psychedelic Program Coordinator. They talk about reframing addiction, the ways society divides us by accepted behaviors, how being taught to doubt ourselves as children creates trauma, the idea of the “disease narrative” and self-demonization, how research studies support the idea of the quick fix, and harm reduction as a pathway to a better self.

The post PT294 – Andrew Tatarsky, Ph.D. & Juliana Mulligan – Vital Psychedelic Conversations appeared first on Psychedelics Today.

Previous articleOptimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program
Next articlePsychedelic Bulletin: Tracking LSD Patents; Psilocybin Effective for a Year in Depression; Cybin Partners with Chopra Foundation